Epioxa from Glaukos is the first epithelium-on corneal cross-linking treatment that has been FDA approved in the United ...

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

Please provide your email address to receive an email when new articles are posted on . In the world of technology, disruptors are sought-after and celebrated. When Roy S. Rubinfeld, MD, MA, led the ...

(MASS APPEAL) – If you’ve been diagnosed with Keratoconus then Corneal Cross Linking might get you back to better eyesight. Mass Appeal’s Patrick Berry joined Dr. John P. Frangie, MD to learn more.